Federated Hermes
ONC

Federated Hermes’s BeOne Medicines Ltd ONC Stock Holding History

Federated Hermes’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,600
Closed -$792K – 2326
2018
Q3 		$792K Sell
4,600
-3,400
-43% -$572K ﹤0.01% 1402
2018
Q2 		$1.23M Sell
8,000
-1,000
-11% -$178K ﹤0.01% 1216
2018
Q1 		$1.51M Buy
+9,000
New +$1.22M ﹤0.01% 1074

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Federated Hermes's ONC Position: Q4 2018 in Review

Federated Hermes sold out of BeOne Medicines Ltd (ONC) in Q4 2018, closing a stake of 4,600 shares — an estimated $792K sold.

Federated Hermes first reported a position in ONC in Q1 2018 and held it in 3 quarters. The position peaked at $1.51M in Q1 2018. 192 funds tracked by Wall St. Rank hold ONC as of Q4 2018.

  • Federated Hermes reported no remaining BeOne Medicines Ltd position as of Q4 2018 after selling out during the quarter.
  • Federated Hermes sold 4,600 BeOne Medicines Ltd shares in Q4 2018, an estimated $792K.
  • Federated Hermes first reported a position in BeOne Medicines Ltd in Q1 2018 and held it in 3 quarters.
  • Federated Hermes's BeOne Medicines Ltd position peaked at $1.51M in Q1 2018.
  • 192 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2018.

Based on Federated Hermes's 13F filing for Q4 2018, filed 13 Feb 2019.